These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28169285)

  • 1. A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.
    Miner PB; Koltun WD; Wiener GJ; De La Portilla M; Prieto B; Shailubhai K; Layton MB; Barrow L; Magnus L; Griffin PH
    Am J Gastroenterol; 2017 Apr; 112(4):613-621. PubMed ID: 28169285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plecanatide Is Effective and Safe in the Treatment for Chronic Idiopathic Constipation: Results of a Phase II Trial.
    Barish C; Dorn S; Fogel RP; Patel R; Rosenberg J
    Dig Dis Sci; 2021 Feb; 66(2):537-540. PubMed ID: 32185662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older.
    Menees SB; Franklin H; Chey WD
    Clin Ther; 2020 Jul; 42(7):1406-1414.e4. PubMed ID: 32660770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
    Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
    Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Schoenfeld P; Lacy BE; Chey WD; Lembo AJ; Kurtz CB; Reasner DS; Bochenek W; Tripp K; Currie MG; Fox SM; Blakesley RE; OʼDea CR; Omniewski ND; Hall ML
    Am J Gastroenterol; 2018 Jan; 113(1):105-114. PubMed ID: 29091082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation.
    DeMicco M; Barrow L; Hickey B; Shailubhai K; Griffin P
    Therap Adv Gastroenterol; 2017 Nov; 10(11):837-851. PubMed ID: 29147135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials.
    Moshiree B; Schoenfeld P; Franklin H; Rezaie A
    Clin Ther; 2022 Jan; 44(1):98-110.e1. PubMed ID: 35086735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation.
    Cash BD; Sharma A; Walker A; Laitman AP; Chang L
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14632. PubMed ID: 37332239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation.
    Rao SSC
    Therap Adv Gastroenterol; 2018; 11():1756284818777945. PubMed ID: 29942351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plecanatide for the treatment of chronic idiopathic constipation in adult patients.
    Bassotti G; Usai Satta P; Bellini M
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1019-1026. PubMed ID: 31575291
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED; Kim HM; Schoenfeld P
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
    Brenner DM; Sharma A; Rao SSC; Laitman AP; Heimanson Z; Allen C; Sayuk GS
    Dig Dis Sci; 2024 May; 69(5):1731-1738. PubMed ID: 38594429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide.
    Rao SSC; Laitman AP; Miner PB
    Clin Transl Gastroenterol; 2023 Jul; 14(7):e00598. PubMed ID: 37162147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome.
    Miner PB
    Expert Opin Pharmacother; 2018 Feb; 19(2):177-183. PubMed ID: 29376436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plecanatide: First Global Approval.
    Al-Salama ZT; Syed YY
    Drugs; 2017 Apr; 77(5):593-598. PubMed ID: 28255961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.
    Chey WD; Camilleri M; Chang L; Rikner L; Graffner H
    Am J Gastroenterol; 2011 Oct; 106(10):1803-12. PubMed ID: 21606974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study.
    Barish CF; Griffin P
    Curr Med Res Opin; 2018 Apr; 34(4):751-755. PubMed ID: 29343131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
    Lacy BE; Schey R; Shiff SJ; Lavins BJ; Fox SM; Jia XD; Blakesley RE; Hao X; Cronin JA; Currie MG; Kurtz CB; Johnston JM; Lembo AJ
    PLoS One; 2015; 10(7):e0134349. PubMed ID: 26222318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation.
    Miner PB
    Drug Saf; 2019 May; 42(5):603-615. PubMed ID: 30649746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.